News
05-20-2026, 05:30 AM
HER2-positive breast cancer accounts for about 20% of breast cancer cases and is generally associated with more aggressive behavior and a higher risk of distant metastasis, while pathologic complete response (pCR) after neoadjuvant chemotherapy is strongly linked to better survival outcomes.
More... (https://www.news-medical.net/news/20260520/Spatial-modeling-of-tissue-compartments-predicts-breast-cancer-treatment-response.aspx)
More... (https://www.news-medical.net/news/20260520/Spatial-modeling-of-tissue-compartments-predicts-breast-cancer-treatment-response.aspx)